Legal & General Group
DERM icon

Legal & General Group’s Journey Medical DERM Stock Holding History

Legal & General Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.45K Buy
1,801
+454
+34% +$3.52K ﹤0.01% 3224
2025
Q4 		$10.4K Hold
1,347
– – ﹤0.01% 3238
2025
Q3 		$9.59K Hold
1,347
– – ﹤0.01% 3289
2025
Q2 		$9.65K Buy
+1,347
New +$9.31K ﹤0.01% 3299

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's DERM Position: Q1 2026 in Review

Legal & General Group increased its Journey Medical (DERM) stake by 34% in Q1 2026, buying an estimated $3.52K and bringing the position to 1,801 shares worth $8.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3224.

Legal & General Group first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.4K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Legal & General Group held 1,801 shares of Journey Medical worth $8.45K as of Q1 2026.
  • Legal & General Group bought 454 Journey Medical shares in Q1 2026, an estimated $3.52K.
  • Journey Medical made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3224 holding.
  • Legal & General Group first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Legal & General Group's Journey Medical position peaked at $10.4K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.